Search Count: 47
 |
C-Terminal Bromodomain Of Human Brd2 With 5-(1-Benzyl-4-Chloro-1H-Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2024-06-26 Classification: TRANSCRIPTION Ligands: EDO, PE4, A1IBV |
 |
N-Terminal Bromodomain Of Human Brd4 With (5-(4-Chloro-1-((Tetrahydro-2H-Pyran-4-Yl)Methyl)-1H-Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2024-06-26 Classification: TRANSCRIPTION Ligands: EDO, A1IB5 |
 |
C-Terminal Bromodomain Of Human Brd2 With 7,8-Dimethoxy-3-Methyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, P4M, MES |
 |
C-Terminal Bromodomain Of Human Brd2 With (R)-7-((R)-1,2-Dihydroxyethyl)-1,3-Dimethyl-5-(1-Methyl-1H-Pyrazol-4-Yl)-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, 7PE, P4X |
 |
C-Terminal Bromodomain Of Human Brd2 With 7,8-Dimethoxy-1,3-Dimethyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, PE4, P0U |
 |
C-Terminal Bromodomain Of Human Brd2 With 7,8-Dimethoxy-1,3-Dimethyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, PE4, P3R |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.17 Å Release Date: 2021-10-06 Classification: TRANSCRIPTION Ligands: 5Z4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.31 Å Release Date: 2021-10-06 Classification: TRANSCRIPTION Ligands: 5YY |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2021-10-06 Classification: TRANSCRIPTION Ligands: 5Z1 |
 |
Pi3 Kinase Delta In Complex With 5-[3,6-Dihydro-2H-Pyran-4-Yl]-2-Methoxy-N-[2-Methylpyridin-4-Yl]Pyridine-3-Sulfonamide
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.49 Å Release Date: 2021-09-29 Classification: SIGNALING PROTEIN Ligands: 7VT |
 |
Pi3 Kinase Delta In Complex With N-[2-(2-Fluoro-4-{[4-(Propan-2-Yl)Piperazin-1-Yl]Methyl}Phenyl)Pyridin-4-Yl]-2-Methoxy-5-(Morpholin-4-Yl)Pyridine-3-Sulfonamide
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.26 Å Release Date: 2021-09-29 Classification: SIGNALING PROTEIN Ligands: 7XH |
 |
Pi3 Kinase Delta In Complex With 5-(3,6-Dihydro-2H-Pyran-4-Yl)-2-Methoxy-N-(5-{3-[4-(Propan-2-Yl)Piperazin-1-Yl]Prop-1-Yn-1-Yl}Pyridin-3-Yl)Pyridine-3-Sulfonamide
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.49 Å Release Date: 2021-09-29 Classification: SIGNALING PROTEIN Ligands: 7XN |
 |
Pi3 Kinase Delta In Complex With N-[5-(3,6-Dihydro-2H-Pyran-4-Yl)-2-Methoxypyridin-3-Yl]Benzenesulfonamide
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.39 Å Release Date: 2021-09-29 Classification: SIGNALING PROTEIN Ligands: 7XW |
 |
N-Terminal Bromodomain Of Human Brd4 With 3-(3-(But-3-Yn-1-Yl)-3H-Diazirin-3-Yl)-N-(3-Methyl-[1,2,4]Triazolo[4,3-A]Pyridin-8-Yl)Propanamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.44 Å Release Date: 2020-10-21 Classification: TRANSCRIPTION Ligands: R5W, EDO |
 |
N-Terminal Bromodomain Of Human Brd2 With 5-(4-(4-Fluorophenyl)-1H-Imidazol-5-Yl)-1-Methylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.26 Å Release Date: 2020-02-19 Classification: TRANSCRIPTION Ligands: SO4, NUQ, EDO |
 |
N-Terminal Bromodomain Of Human Brd4 With 1-((1-Acetylpiperidin-4-Yl)Methyl)-2-(4-Hydroxy-3,5-Dimethylphenyl)-N-Methyl-1H-Benzo[D]Imidazole-5-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2020-01-15 Classification: TRANSCRIPTION Ligands: NUW, EDO |
 |
N-Terminal Bromodomain Of Human Brd4 With 1,3-Dimethyl-5-(1-((Tetrahydro-2H-Pyran-4-Yl)Methyl)-1H-Benzo[D]Imidazol-2-Yl)Pyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2020-01-15 Classification: TRANSCRIPTION Ligands: EDO, NUB |
 |
N-Terminal Bromodomain Of Human Brd4 With 5-(1-(1,3-Dimethoxypropan-2-Yl)-5-Morpholino-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2020-01-15 Classification: TRANSCRIPTION Ligands: EDO, NV2 |
 |
N-Terminal Bromodomain Of Human Brd4 With 5-(1-(1,3-Dimethoxypropan-2-Yl)-5-Morpholino-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2020-01-15 Classification: TRANSCRIPTION Ligands: SO4, NUH, EDO |
 |
Crystal Structure Of Human Lipoprotein-Associated Phospholipase A2 In Complex With A [1.1.1]Bicyclopentane-Containing Inhibitor At 1.91A Resolution.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2017-02-01 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: CL, 71H |